Bvf Inc has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $3.15 Billion distributed in 55 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Moon Lake Immunotherapeutics with a value of $1.1B, Kymera Therapeutics, Inc. with a value of $244M, Revolution Medicines, Inc. with a value of $158M, Mirum Pharmaceuticals, Inc. with a value of $120M, and Tyra Biosciences, Inc. with a value of $110M.

Examining the 13F form we can see an decrease of $124M in the current position value, from $3.27B to 3.15B.

Bvf Inc is based out at San Francisco, CA

Below you can find more details about Bvf Inc portfolio as well as his latest detailed transactions.

Portfolio value $3.15 Billion
Healthcare: $3.15 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 55
  • Current Value $3.15 Billion
  • Prior Value $3.27 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 5 stocks
  • Additional Purchases 6 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.